It took 27 years, but Cytokinetics secured its first U.S. drug approval. On Friday, the Food and Drug Administration cleared ...
Is the biotech industry truly out of its slump? This week on "The Readout LOUD," a biotech year in review and a look ahead to ...
Discover how intellectual property rights protect exclusive pharmaceutical use and brand names in biotechnology, influencing innovation and market dynamics.
The final report, presented to New York Governor Kathy Hochul, outlines a path to translate investments in the state's biotech ecosystem into real-world outcomes. -- Executives from The Michael J. Fox ...
Norgine, a leading European specialty pharmaceutical company, today announced an exclusive licensing agreement under which ...
And what a year it has been! Artificial intelligence is being incorporated into more aspects of our lives, weight-loss drugs ...
Microbial biotechnology is a dynamic field, The origins of microbiology can be traced back to the pioneering research by scientists such as Louis Pasteur and Robert Koch in the 19 th century. Within a ...
Agriculture, from the outset, has been made possible by humans tweaking the genes of plants to make them grow faster, produce ...
Biotechnology is a curious marriage of two seemingly disparate worlds. On one end, we have living organisms—wild, unpredictable celestial creations that can probably never be understood or appreciated ...
InvestorsHub on MSN
Lixte Biotechnology shares dip after $4.3 million registered direct offering
Lixte Biotechnology Holdings Inc. (NASDAQ:LIXT) shares slipped 2.5% after the company announced a $4.3 million registered ...
A catalyst for technology-based economic development in life sciences . In 1984, three of North Carolina’s largest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results